12:29 PM EST - Braxia Scientific Corp : Announces that Health Canada has approved the Company's application to the Special Access Program to provide psilocybin-assisted psychotherapy for a patient with Major Depressive Disorder in Ontario, through its wholly owned subsidiary Canadian Rapid Treatment Centre of Excellence. Braxia Scientific Corp
shares C.BRAX are trading up 9.1% at $0.06.
